Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.

MLA

Reiner, Anne S., et al. “Hormone Receptor Status of a First Primary Breast Cancer Predicts Contralateral Breast Cancer Risk in the WECARE Study Population.” Breast Cancer Research, vol. 19, July 2017, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13058-017-0874-x.

APA

Reiner, A. S., Lynch, C. F., Sisti, J. S., John, E. M., Brooks, J. D., Bernstein, L., Knight, J. A., Li Hsu, Concannon, P., Mellemkjær, L., Tischkowitz, M., Haile, R. W., Ronglai Shen, Malone, K. E., Woods, M., Xiaolin Liang, Morrow, M., Bernstein, J. L., Hsu, L., & Shen, R. (2017). Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Research, 19, 1–11. https://doi.org/10.1186/s13058-017-0874-x

Chicago

Reiner, Anne S., Charles F. Lynch, Julia S. Sisti, Esther M. John, Jennifer D. Brooks, Leslie Bernstein, Julia A. Knight, et al. 2017. “Hormone Receptor Status of a First Primary Breast Cancer Predicts Contralateral Breast Cancer Risk in the WECARE Study Population.” Breast Cancer Research 19 (July): 1–11. doi:10.1186/s13058-017-0874-x.